EUCTR2015-004111-20-FI进行中（未招募）不适用
Photodynamic therapy for Lentigo maligna with 5-aminolaevulinic acid nanoemulsion (BF-200 ALA)
Janne Räsänen0 个研究点开始时间: 2015年9月29日最近更新:
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Patients with non-invasiveLentigo maligna located in the skin of face, neck or upper body region.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 5
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 10
排除标准
- •Biopsy shows invasive melanoma inside Lentigo maligna lesion prior treatment. Porfyria or solar dermatitis. Allergy for
- •photosensitizers used in study. Pregnant or breastfeeding patients.
研究者
相似试验
招募中
不适用
Photodynamic therapy with topical 5-aminolevulinic acid for the treatment of skin cancersskin cancersJPRN-UMIN000004329Department of Plastic and Reconstructive Surgery, Osaka City University, Graduate School of Medicine10
招募中
不适用
Photodynamic therapy with oral administration of 5-aminolevulinic acid for the treatment of skin cancers and hair follicle sebaceous glands tumorsSkin cancers and hair follicle sebaceous glands tumorsJPRN-UMIN000007523Department of Plastic and Reconstructive Surgery, Osaka City University, Graduate School of Medicine20
已完成
不适用
Efficacy of photodynamic therapy (PDT) of 5-Aminolevulinic Acid for cervical intraepithelial neoplasiacervical intraepithelial neoplasia(CIN)JPRN-UMIN000010412agoya University Graduate School of Medicine120
进行中（未招募）
不适用
ALA-PDT for premalignant vulvar disorders.EUCTR2011-003134-13-NLErasmus MC
已完成
2 期
5-AMINOLEVULINIC ACID PHOTODYNAMIC THERAPY FOR THE TREATMENT OF PREMALIGNANT DISORDERS OF THE VULVAhigh grade squamous intraepithelial lesion (HSIL) and vulvar lichen sclerosus (VLS): premalignant vulvar disorders1004778910040900NL-OMON47821Erasmus MC, Universitair Medisch Centrum Rotterdam180